Magenta Therapeutics Inc. (NASDAQ: MGTA) started the day on February 19, 2021, with a price increase of 16.56% at $10.77. During the day, the stock rose to $10.85 and sunk to $9.30 before settling in for the price of $9.24 at the close. Taking a more long-term approach, MGTA posted a 52-week range of $5.76-$14.25.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 33.80%. This publicly-traded company’s shares outstanding now amounts to $48.26 million, simultaneously with a float of $42.61 million. The organization now has a market capitalization sitting at $446.31 million. At the time of writing, stock’s 50-day Moving Average stood at $8.56, while the 200-day Moving Average is $7.96.
Magenta Therapeutics Inc. (MGTA) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Magenta Therapeutics Inc.’s current insider ownership accounts for 11.79%, in contrast to 71.60% institutional ownership. According to the most recent insider trade that took place on Jun 29, this organization’s Director bought 1,250,000 shares at the rate of 8.00, making the entire transaction reach 10,000,000 in total value, affecting insider ownership by 1,250,000.
Magenta Therapeutics Inc. (MGTA) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2020, the organization reported -$0.37 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.45) by $0.08. This company achieved a return on equity of -53.53. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
Magenta Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 33.80% and is forecasted to reach -1.75 in the upcoming year.
Magenta Therapeutics Inc. (NASDAQ: MGTA) Trading Performance Indicators
Let’s observe the current performance indicators for Magenta Therapeutics Inc. (MGTA). It’s Quick Ratio in the last reported quarter now stands at 16.70. The Stock has managed to achieve an average true range (ATR) of 0.75.
In the same vein, MGTA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.95, a figure that is expected to reach -0.42 in the next quarter, and analysts are predicting that it will be -1.75 at the market close of one year from today.
Technical Analysis of Magenta Therapeutics Inc. (MGTA)
If we take a close look at the recent performances of Magenta Therapeutics Inc. (NASDAQ: MGTA), its last 5-days Average volume was 0.53 million that shows progress from its year to date volume of 0.32 million. During the previous 9 days, stock’s Stochastic %D was recorded 35.38% While, its Average True Range was 0.82.
Raw Stochastic average of Magenta Therapeutics Inc. (MGTA) in the period of the previous 100 days is set at 89.94%, which indicates a major rise in contrast to 80.22% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 91.31% that was higher than 59.23% volatility it exhibited in the past 100-days period.